Barinthus Bio Reports Positive Phase 1 Data for VTP-1000
Germantown, MD – December 10, 2025 – Barinthus Biotherapeutics announced new results from the Phase 1 AVALON clinical trial...
Gozellix
Advertisement
Telix and Varian Launch Theranostics-EBRT Precision Oncology Collaboration
Melbourne, Australia & Palo Alto, CA – December 10, 2025 – Telix Pharmaceuticals Limited and Varian, a Siemens Healthineers...
Advertisement
